GlassScriptPhysician profile
Paulo Castaneda
NPI 1013536945
$13,648.44
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $477 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $4,244 · Food and Beverage: $3,949 · Education: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $4,244.34 |
| Food and Beverage | $3,948.65 |
| Education | $455.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,805.90 | 2025 | Pro, Am, Pangea |
| Smith+Nephew, INC. | $5,000.00 | 2025 | |
| Kls-Martin L.P. | $1,364.63 | 2025 | |
| Arthrex, INC. | $477.30 | 2024 | |
| Zimmer Biomet Holdings, INC. | $303.33 | 2025 | Persona |
| Depuy Synthes Sales INC. | $273.11 | 2025 | Na, Tfn-Advance |
| Exactech, INC. | $166.38 | 2025 | |
| Foundation Medical, LLC | $91.27 | 2025 | |
| Orthopediatrics Corp. | $70.86 | 2025 | |
| Impactortho, INC. | $70.52 | 2025 | |
| Medical Device Business Services, INC. | $25.14 | 2025 | Inhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paulo Castaneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.